Encapsulation of Exenatide in Poly-(d,l-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes
出版年份 2011 全文链接
标题
Encapsulation of Exenatide in Poly-(d,l-Lactide-Co-Glycolide) Microspheres Produced an Investigational Long-Acting Once-Weekly Formulation for Type 2 Diabetes
作者
关键词
-
出版物
Diabetes Technology & Therapeutics
Volume 13, Issue 11, Pages 1145-1154
出版商
Mary Ann Liebert Inc
发表日期
2011-07-14
DOI
10.1089/dia.2011.0050
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- An overview of once-weekly glucagon-like peptide-1 receptor agonists-available efficacy and safety data and perspectives for the future
- (2011) S. Madsbad et al. DIABETES OBESITY & METABOLISM
- DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide
- (2011) C. Wysham et al. DIABETIC MEDICINE
- DURATION-5: Exenatide Once Weekly Resulted in Greater Improvements in Glycemic Control Compared with Exenatide Twice Daily in Patients with Type 2 Diabetes
- (2011) Thomas Blevins et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pharmacokinetics and Pharmacodynamics of Exenatide Extended-Release After Single and Multiple Dosing
- (2010) Mark Fineman et al. CLINICAL PHARMACOKINETICS
- A review of efficacy and safety data regarding the use of liraglutide, a once-daily human glucagon-like peptide 1 analogue, in the treatment of type 2 diabetes mellitus
- (2010) Eduard Montanya et al. CLINICAL THERAPEUTICS
- DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks
- (2010) J. B. Buse et al. DIABETES CARE
- Risperidone Long-Acting Injection
- (2010) Emma D. Deeks DRUGS
- Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder
- (2010) Andrea Fagiolini et al. EXPERT OPINION ON PHARMACOTHERAPY
- Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial
- (2010) Michaela Diamant et al. LANCET
- Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial
- (2010) Richard M Bergenstal et al. LANCET
- Incretin Therapies: Effects Beyond Glycemic Control
- (2009) Sunder Mudaliar et al. AMERICAN JOURNAL OF MEDICINE
- Exenatide: a review from pharmacology to clinical practice
- (2009) R. Gentilella et al. DIABETES OBESITY & METABOLISM
- Exenatide efficacy and safety: a systematic review
- (2009) S. L. Norris et al. DIABETIC MEDICINE
- Incretin-based therapies for type 2 diabetes mellitus
- (2009) Julie A. Lovshin et al. Nature Reviews Endocrinology
- Clinical Studies of Liraglutide, a Novel, Once-Daily Human Glucagon-Like Peptide-1 Analog for Improved Management of Type 2 Diabetes Mellitus
- (2009) Scott R Drab PHARMACOTHERAPY
- Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study
- (2008) Daniel J Drucker et al. LANCET
- Foreign body reaction to biomaterials
- (2008) James M. Anderson et al. SEMINARS IN IMMUNOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started